The C-X-C chemokine receptor (CXCR)3 and its chemokines (CXCL9, CXCL10, CXCL11) are involved in the pathogenesis of autoimmune thyroiditis (AT), Graves' disease (GD) and Graves' Ophthalmopathy (GO). Under the influence of interferon(IFN)γ, the IFNγ-induced protein 10 (IP-10/CXCL10) is secreted by thyrocytes, orbital fibroblasts and preadipocytes. In tissue, Th1 lymphocytes are recruited; hence IFNγ is enhanced, which stimulates CXCL10 secretion reiterating the autoimmune process. The presence of elevated levels of CXCL10 in peripheral liquids is considered a marker of Th1 orientated immune response. High levels of circulating CXCL10 (sCXCL10) have been shown in patients with AT, overall with hypothyroidism. In GD and GO patients high sCXCL10 have been shown particularly in the active disease. A modulatory role of peroxisome proliferator-activated receptor (PPAR)γ or - α agonists on CXCR3 chemokines in AT, GD and GO and the immuno-modulatory effect of methimazole on CXCR3 chemokines in GD have been shown. Further studies are ongoing to explore the use of new molecules that act as antagonists of CXCR3, or block CXCL10, in autoimmune disorders, and many interesting patents have been recently applied.

Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity / Fallahi, Poupak; Ferrari, Silvia Martina; Corrado, Alda; Giuggioli, Dilia; Ferri, Clodoveo; Antonelli, Alessandro. - In: RECENT PATENTS ON ENDOCRINE, METABOLIC & IMMUNE DRUG DISCOVERY. - ISSN 1872-2148. - STAMPA. - 8:(2014), pp. 95-101. [10.2174/1872214808666140623114315]

Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity

FERRARI, Silvia Martina;Giuggioli, Dilia;FERRI, Clodoveo;
2014

Abstract

The C-X-C chemokine receptor (CXCR)3 and its chemokines (CXCL9, CXCL10, CXCL11) are involved in the pathogenesis of autoimmune thyroiditis (AT), Graves' disease (GD) and Graves' Ophthalmopathy (GO). Under the influence of interferon(IFN)γ, the IFNγ-induced protein 10 (IP-10/CXCL10) is secreted by thyrocytes, orbital fibroblasts and preadipocytes. In tissue, Th1 lymphocytes are recruited; hence IFNγ is enhanced, which stimulates CXCL10 secretion reiterating the autoimmune process. The presence of elevated levels of CXCL10 in peripheral liquids is considered a marker of Th1 orientated immune response. High levels of circulating CXCL10 (sCXCL10) have been shown in patients with AT, overall with hypothyroidism. In GD and GO patients high sCXCL10 have been shown particularly in the active disease. A modulatory role of peroxisome proliferator-activated receptor (PPAR)γ or - α agonists on CXCR3 chemokines in AT, GD and GO and the immuno-modulatory effect of methimazole on CXCR3 chemokines in GD have been shown. Further studies are ongoing to explore the use of new molecules that act as antagonists of CXCR3, or block CXCL10, in autoimmune disorders, and many interesting patents have been recently applied.
2014
8
95
101
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity / Fallahi, Poupak; Ferrari, Silvia Martina; Corrado, Alda; Giuggioli, Dilia; Ferri, Clodoveo; Antonelli, Alessandro. - In: RECENT PATENTS ON ENDOCRINE, METABOLIC & IMMUNE DRUG DISCOVERY. - ISSN 1872-2148. - STAMPA. - 8:(2014), pp. 95-101. [10.2174/1872214808666140623114315]
Fallahi, Poupak; Ferrari, Silvia Martina; Corrado, Alda; Giuggioli, Dilia; Ferri, Clodoveo; Antonelli, Alessandro
File in questo prodotto:
File Dimensione Formato  
Fallahi CXCR3 tiroide.pdf

Solo gestori archivio

Descrizione: articolo finale
Tipologia: Versione pubblicata dall'editore
Dimensione 4.64 MB
Formato Adobe PDF
4.64 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1063906
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 10
  • ???jsp.display-item.citation.isi??? ND
social impact